Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Pancreatic Neoplasms 8Multiple Myeloma 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Prostatic Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Inflammation 2Frailty 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Ventilator-Induced Lung Injury 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Postoperative Complications 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Mucositis 1

Interventions

Rituximab 208Cyclophosphamide 167Etoposide 83Prednisone 79Vincristine 77Doxorubicin 76Peripheral Blood Stem Cell Transplantation 61Filgrastim 55Cytarabine 47fludarabine phosphate 46Radiotherapy 43Lenalidomide 41Mycophenolic Acid 40Tacrolimus 36Methotrexate 35Melphalan 35Busulfan 35Gemcitabine 32Carmustine 32Cyclosporine 31Whole-Body Irradiation 29Ifosfamide 28Antilymphocyte Serum 26zanubrutinib 25polatuzumab vedotin 25Dexamethasone 23Methylprednisolone 22ibritumomab tiuxetan 20Carboplatin 20Oxaliplatin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma, Large B-Cell, Diffuse × Ascorbic Acid × Clear all
NCT03418038 2026-04-16

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Mayo Clinic

Phase 2 Recruiting
80 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡